Clearside Biomedical, Inc. (CLSD)
USD 0.97
(-4.9%)
USD 0.97
(-4.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.22 Million | 1.32 Million | 29.57 Million | 7.89 Million | 2.17 Million | 30 Thousand |
| Cost of Revenue | 355 Thousand | 204 Thousand | 178 Thousand | - | - | - |
| Gross Profit | 7.87 Million | 1.12 Million | 29.39 Million | 7.89 Million | 2.17 Million | 30 Thousand |
| Operating Expenses | 32.71 Million | 31.4 Million | 30.2 Million | 25.82 Million | 32.47 Million | 82.97 Million |
| Selling, General and Administrative Expenses | 11.86 Million | 11.77 Million | 11.66 Million | 10.75 Million | 16.81 Million | 14.68 Million |
| Research and Development Expenses | 20.84 Million | 19.63 Million | 18.53 Million | 15.07 Million | 15.65 Million | 68.29 Million |
| Other Expenses | - | 669 Thousand | 1 Million | -275 Thousand | -466 Thousand | 127 Thousand |
| Cost and Expenses | 33.07 Million | 31.6 Million | 30.2 Million | 25.82 Million | 32.47 Million | 82.97 Million |
| Operating Income | -24.84 Million | -30.27 Million | -627 Thousand | -17.93 Million | -30.3 Million | -82.94 Million |
| Interest Expense | 9.36 Million | 3.33 Million | - | 335 Thousand | 1.03 Million | - |
| Income Tax Expense | - | 1.12 Million | -58.55 Thousand | -180 Thousand | -211 Thousand | 127 Thousand |
| Earnings before Tax | -32.48 Million | -32.94 Million | 376 Thousand | -18.21 Million | -30.77 Million | -82.81 Million |
| Net Income | -32.48 Million | -34.07 Million | 376 Thousand | -18.03 Million | -30.55 Million | -82.81 Million |
| Earnings Per Share Basic | -0.53 | -0.57 | 0.01 | -0.39 | -0.80 | -2.69 |
| Earnings Per Share Diluted | -0.53 | -0.57 | 0.01 | -0.39 | -0.80 | -2.69 |
| Weighted Average Shares Outstanding | 61.8 Million | 60.2 Million | 58.49 Million | 46.5 Million | 38.17 Million | 30.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.8 Million | 60.2 Million | 59.9 Million | 46.5 Million | 38.17 Million | 30.73 Million |
| Gross Margin | 0.96 | 0.85 | 0.99 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -2.80 | -22.31 | -0.02 | -2.27 | -13.95 | -2764.83 |
| Profit Margin | -3.95 | -25.68 | 0.01 | -2.28 | -14.06 | -2760.60 |
| EBITDA | -23.05 Million | -29.46 Million | -449 Thousand | -17.93 Million | -30.09 Million | -82.75 Million |
| Earnings Before Tax Margin | -3.02 | -22.82 | -0.02 | -2.27 | -13.95 | -2764.83 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 90 Thousand | 230 Thousand | 6.34 Million | 8.22 Million | 859 Thousand | 1.01 Million |
| Cost of Revenue | 44 Thousand | 28 Thousand | 20 Thousand | 422 Thousand | 142 Thousand | 213 Thousand |
| Gross Profit | 46 Thousand | 202 Thousand | 6.32 Million | 7.8 Million | 717 Thousand | 805 Thousand |
| Operating Expenses | 7.63 Million | 8.41 Million | 9.24 Million | 32.64 Million | 7.91 Million | 8.07 Million |
| Selling, General and Administrative Expenses | 3.07 Million | 2.82 Million | 2.94 Million | - | 2.63 Million | 3.12 Million |
| Research and Development Expenses | 4.55 Million | 5.58 Million | 6.29 Million | - | 5.13 Million | 4.94 Million |
| Other Expenses | 1.91 Million | -1.49 Million | 360 Thousand | 1.71 Million | 142 Thousand | 458 Thousand |
| Cost and Expenses | 7.68 Million | 8.43 Million | 9.26 Million | 33.07 Million | 7.91 Million | 8.28 Million |
| Operating Income | -7.59 Million | -8.2 Million | -2.91 Million | -24.84 Million | -7.05 Million | -7.27 Million |
| Interest Expense | 2.34 Million | 2.4 Million | 2.27 Million | 9.36 Million | -2.62 Million | 2.29 Million |
| Income Tax Expense | - | 1.00 | -6.57 Million | -100.89 Thousand | -16 Thousand | 2.75 Million |
| Earnings before Tax | -7.59 Million | -11.76 Million | -4.83 Million | -32.48 Million | -9.26 Million | -9.1 Million |
| Net Income | -7.59 Million | -11.76 Million | -4.83 Million | -32.48 Million | -9.26 Million | -9.1 Million |
| Earnings Per Share Basic | -0.10 | -0.17 | -0.08 | - | -0.15 | -0.15 |
| Earnings Per Share Diluted | -0.10 | -0.17 | -0.08 | - | -0.15 | -0.15 |
| Weighted Average Shares Outstanding | 74.73 Million | 69.85 Million | 62.4 Million | 61.8 Million | 61.98 Million | 61.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.73 Million | 69.85 Million | 62.4 Million | 61.8 Million | 61.98 Million | 61.65 Million |
| Gross Margin | 0.51 | 0.88 | 1.00 | 0.95 | 0.83 | 0.79 |
| EBIT Margin | -83.84 | -35.57 | -0.46 | - | -8.21 | -6.68 |
| Profit Margin | -84.38 | -51.14 | -0.76 | -3.95 | -10.79 | -8.94 |
| EBITDA | -7.54 Million | -8.18 Million | -2.89 Million | - | -7.05 Million | -6.79 Million |
| Earnings Before Tax Margin | -84.33 | -35.69 | -0.46 | -3.02 | -8.21 | -7.14 |
TWD
EZTD
PCMC
FTTRF
SBGLP
PTCO